EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma

Saskia Tauch, Bettina Kast, Sabrina Lohr, Lowis Kemm, Melanie Sator-Schmitt, Nicolas Gengenbacher, Hellmut G Augustin, Peter Angel iD

Molecular Carcinogenesis · 2025-02 · 64 (2) · 215-220

DOI: 10.1002/mc.23841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 08.11.2024. Verfasst von Saskia Tauch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division Signal Transduction and Growth Control, German Cancer Research Center (DKFZ-ZMBH Alliance), Heidelberg, Germany. Hauptthemen laut MEDLINE: Membrane Glycoproteins, Melanoma, Cancer-Associated Fibroblasts, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Within the tumor microenvironment (TME), cancer‐associated fibroblasts (CAFs) were shown to be an active and pivotal cell population, supporting many protumorigenic mechanisms. Podoplanin (PDPN)‐positive CAFs are of special interest since their abundance correlated with a worse prognosis for patients of different cancer entities, including malignant melanoma. In this study, we applied a loss‐of‐function approach in an in vivo mouse melanoma model to evaluate the contribution of CAF‐specific PDPN expression to melanoma formation and progression. Surprisingly, despite its prominent expression in CAFs deletion of PDPN in this cell type did neither affect the onset, nor growth of MM tumors. These data imply that PDPN expression in CAFs represents a biomarker for poor prognosis but does not serve as a useful target for stroma‐directed therapy of malignant melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane GlycoproteinsMelanomaCancer-Associated FibroblastsSkin NeoplasmsAnimalsMiceTumor MicroenvironmentHumansGene Expression Regulation, NeoplasticBiomarkers, TumorPodoplanin

Stichwörter der Autor:innen

CAFGEMM modelTMEmelanomapodoplanin

Substanzen

Membrane GlycoproteinsBiomarkers, TumorPodoplaninPdpn protein, mousePDPN protein, human

Autor:innen und Institutionen

  • Division Signal Transduction and Growth Control, German Cancer Research Center (DKFZ-ZMBH Alliance), Heidelberg, Germany.
  • Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ-ZMBH Alliance), Heidelberg, Germany.
  • European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • DKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, Germany.

ORCID-Profile: Peter Angel

Zitieren

APA

Tauch, S., Kast, B., Lohr, S., Kemm, L., Sator-Schmitt, M., Gengenbacher, N., Augustin, H. G., & Angel, P. (2025). CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma. Molecular Carcinogenesis, 64(2), 215-220. https://doi.org/10.1002/mc.23841

Vancouver

Tauch S, Kast B, Lohr S, Kemm L, Sator-Schmitt M, Gengenbacher N, et al. CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma. Molecular Carcinogenesis. 2025;64(2):215-220. doi:10.1002/mc.23841

BibTeX
@article{Tauch2025,
  author = {Tauch, Saskia and Kast, Bettina and Lohr, Sabrina and Kemm, Lowis and Sator-Schmitt, Melanie and Gengenbacher, Nicolas and Augustin, Hellmut G and Angel, Peter},
  title = {CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  volume = {64},
  number = {2},
  pages = {215--220},
  doi = {10.1002/mc.23841}
}
Kostenlos starten →